Clinical trial
New Care Pathways to Achieve HCV Elimination in the Community: Real-world Outcomes From HCV Infected Patients Treated in Addiction Centers in France
NCT04366973 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New Care Pathways to Achieve HCV Elimination in the Community: Real-world Outcomes From HCV Infected Patients Treated in Addiction Centers in France
- Lead sponsor
- AbbVie
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 26, 2020
- Completion date
- December 31, 2023
- Enrollment
- 95 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis c virus (hcv)